Sivelestat
- Level
- Commodity
- Parent
- 51161700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161721This classification denotes a protease inhibitor with the molecular formula C20H22N2O7S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DWI62G0P59, chemically known as o-(p-hydroxybenzenesulfonamido)hippuric acid, pivalate (ester) but generally known as sivelestat, which bears US NIH Compound Identifier 107706. European Medicines Agency schedules Sivelestat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10543MIG. The term SIVELESTAT is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 12 No. 2 1999, List 40). Most nations schedule sivelestat under HS 29350090 and SITC 51580. As of Q4 2014, SIVELESTAT remains the US FDA Preferred Term for this commodity. Sivelestat bears US NLM identifiers UMLS ID C0130137 and NCI Concept Code C66539. SMILES: S(=O)(=O)(NC1C(CCCC1)C(=O)NCC(=O)O)C1CCC(OC(=O)C(C)(C)C)CC1.
Same parent
Under 51161700 · 27Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.